Increased oxidative stresses are implicated in the pathogenesis of Parkinson's disease, and dopaminergic neurons may be intrinsically susceptible to oxidative damage. However, the selective presence of tetrahydrobiopterin (BH 4 ) makes dopaminergic neurons more resistant to oxidative stress caused by glutathione depletion. To further investigate the mechanisms of BH 4 protection, we examined the effects of BH 4 on superoxide levels in individual living mesencephalic neurons. Dopaminergic neurons have intrinsically lower levels of superoxide than nondopaminergic neurons. In addition, inhibiting BH 4 synthesis increased superoxide in dopaminergic neurons, while BH 4 supplementation decreased superoxide in nondopaminergic cells. BH 4 is also a cofactor in catecholamine and NO production. In order to exclude the possibility that the antioxidant effects of BH 4 are mediated by dopamine and NO, we used fibroblasts in which neither catecholamine nor NO production occurs. In fibroblasts, BH 4 decreased baseline reactive oxygen species, and attenuated reactive oxygen species increase by rotenone and antimycin A. Physiologic concentrations of BH 4 directly scavenged superoxide generated by potassium superoxide in vitro. We hypothesize that BH 4 protects dopaminergic neurons from ordinary oxidative stresses generated by dopamine and its metabolites and that environmental insults or genetic defects may disrupt this intrinsic capacity of dopaminergic neurons and contribute to their degeneration in Parkinson's disease.
Parkinson's disease (PD) 1 is characterized by the selective degeneration of dopaminergic neurons in the substantia nigra (SN) pars compacta. While the etiology and pathogenesis of this cell death in most cases of PD remain unknown, it has been widely hypothesized that increased oxidative stress and mitochondrial dysfunction contribute to dopaminergic neuronal degeneration. Autopsy studies have noted numerous abnormalities indicative of increased oxidative damage in the SN (1) (2) (3) (4) (5) .
In particular, decreased glutathione in the SN has been found in autopsy brains from individuals with incidental Lewy bodies, presumed to represent presymptomatic PD (6) . In addition, mitochondrial complex I activity is also decreased in the SN of PD patients (7, 8) , and complex I inhibition can increase the formation of reactive oxygen species (9, 10) . Although these findings suggest that dopaminergic neurons are susceptible to oxidative stress, studies in vivo have not observed dopaminergic neuronal death following the oxidative stress generated by glutathione depletion (11) (12) (13) . Furthermore, mesencephalic dopaminergic neurons in primary monolayer (14) and reaggregate (15) cultures are less susceptible to the toxicity of glutathione depletion than nondopaminergic neurons.
To explain this unanticipated resistance of dopaminergic neurons to oxidative stress, we hypothesized that dopaminergic neurons may contain additional antioxidants for the metabolism of ROS. One candidate is tetrahydrobiopterin (BH 4 ), which is present abundantly in dopaminergic neurons where it functions as a cofactor for tyrosine hydroxylase (TH) in catecholamine synthesis. Recently, BH 4 has also been found to decrease superoxide formed by xanthine/xanthine oxidase (16) , a macrophage/phorbol myristate acetate reaction system (17) , and by NOS (18, 19) , and to protect against a variety of oxidative stressors (20 -23) . BH 4 also mediates the marked preferential resistance of dopaminergic neurons to glutathione depletion (15) . Therefore, BH 4 may provide dopaminergic neurons with an additional pathway for the metabolism of reactive oxygen species (ROS).
In this paper, we delineate a mechanism underlying the increased resistance of dopaminergic neurons to oxidative stress. First, using microfluorimetry of individual living neurons, we show that dopaminergic neurons have lower levels of superoxide than nondopaminergic neurons. We then show that the presence of BH 4 is both sufficient and necessary to maintain low superoxide levels in dopaminergic neurons, and in fibroblasts that have been engineered to synthesize BH 4 but do not produce dopamine or NO. Last, we show that BH 4 decreases superoxide in vitro through a direct scavenging mechanism.
EXPERIMENTAL PROCEDURES
Mesencephalic Cultures-Cultures were prepared as described previously (15) . Briefly, timed pregnant Harlan Sprague-Dawley rats were purchased from Harlan Sprague-Dawley (Madison, WI). Pieces of ventral mesencephalon were dissected from embryonic gestation day 14 (E14) rat embryos (day of conception defined as day 0), and then incubated for 20 min at 37°C in 0.4% trypsin in calcium-and magnesium-free Hanks' balanced salt solution. Pieces were then triturated in 0.015% DNase using flame-polished Pasteur pipettes. Cells were plated onto poly-L-lysine-coated glass coverslips at a density of 200,000 viable cells/cm 2 . Cells were grown in high glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. After 48 h, the medium was changed, and 10 g/ml 5-fluoro-2-deoxyuridine was added to inhibit glial growth. Cells were grown an additional 4 -6 days prior to study. Glia represented less than 15% of the total cells in cultures, based on the number of cells that lacked immunoreactivity to neurofilament protein 200 or neuron-specific nuclear protein (NeuN) antibodies.
Measurement of ROS-Relative superoxide levels were determined by measuring the rate of increase in ethidium (Et) fluorescence generated by the oxidation of hydroethidine (HEt) by superoxide (24) . All measurements were made with a Nikon Diaphot epifluorescence microscope, and illumination with a 150 W Xe arc (attenuated by a neutral density 1.5, ultraviolet-grade filter; Omega Optical, Brattleboro, VT). Et imaging used standard rhodamine optics (excitation 510 -560 nm; dichroic mirror 580 nm; emission Ͼ590 nm) (Nikon, Melville, NY). Images were formed using a 40X Fluor NA 0.85 objective (Nikon) and collected on a Hamamatsu ICCD (sensitivity set at 7.0). Images were 8-bit (256 intensity levels) and 16 frames were averaged every 10 s. Background subtraction was made using the first image obtained when HEt solution was added. Data acquisition was controlled by MetaFluor or MetaMorph software (Universal Imaging Corp.), and average intensity over identified regions of interest were logged to hard disc and displayed in real time. The relative superoxide level for each cell was determined from the slope of the increase in ethidium fluorescence over time, fit by linear regression. HEt, a dye freely permeable to cells (25, 26) , was freshly prepared and used at a final concentration of 3.2 M.
We also measured the oxidation of 2,7-dichlorodihydrofluorescein to 2,7-dichlorofluorescein (DCF) which can be caused by various ROS and reactive nitrogen species (27) . Images were obtained in the presence of 33 M 2,7-dichlorodihydrofluorescein at 5-s intervals for 15 min. Images were corrected by subtracting an autofluoresence image obtained before dye addition. Optics utilized excitation at 460 -490, dichroic mirror 500, emission Ͼ515 nm. Rate of fluorescence increase was determined by fitting a line to the final 5 min by linear regression.
To quantify fluorescence, cell somata were circled, and the average cytosolic fluorescence computed. Because systematic differences in somal volumes between dopaminergic and non-dopaminergic neurons would alter fluorescence intensities, any volume difference could confound our interpretation of ROS differences. Accordingly, mean crosssectional somal areas (and hence cell volume) were compared between dopaminergic and nondopaminergic neurons and were found to be comparable (data not shown).
Immunohistochemitry and Post-hoc Identification of Dopaminergic Neurons-Neurons in which fluorescence measurements were made were identified as either dopaminergic or nondopaminergic based on post-hoc TH-immunohistochemistry. After each study, the location of the field of cells was marked on the slide. Cells were then washed with 0.1 M phosphate-buffered saline, and fixed in 4% paraformaldehyde, 0.1 M phosphate buffer for 15 min. Cells were exposed to 0.6% H 2 O 2 in phosphate-buffered saline for 15 min to remove endogenous peroxidase activity, and preincubated with 0.1 M phosphate-buffered saline containing 1% bovine serum albumin and 0.2% Triton X-100 for 30 min. Cells were incubated at room temperature overnight in primary polyclonal anti-TH antiserum (1:1000). Cultures were next incubated for 1 h with anti-rabbit biotinylated secondary antibody at 1:200 dilution, and an additional 1 h with an avidin-biotin conjugate of peroxidase (Vectastain ABC kit). Dopaminergic neurons were visualized as a black reaction product, using diaminobenzidine tetrahydrochloride in the presence of cobalt chloride (0.02%) and nickel ammonium sulfate (0.02%).
Following immunohistochemistry, the original field of imaged cells field was found and re-imaged. The orientation and location of stained cells were matched, and neurons were identified as dopaminergic or nondopaminergic based on immunostaining.
Western Blot Analysis-Fibroblasts were grown to confluence in T162 flasks prior to harvest. Cells were resuspended in 200 l of phosphate-buffered saline, sonicated and centrifuged at 16,000 ϫ g for 2 min. The supernatant was frozen at Ϫ20°C.
A total of 25 l of supernatant from each sample were electrophoresed on 10% SDS-polyacrylamide electrophoresis gels, and transferred to a polyvinylidene difluoride membrane. Following transfer, membranes were incubated overnight in 5% nonfat milk, and then incubated 1 h with primary antibodies against endothelial NOS (eNOS) at 1:500, inducible NOS (iNOS) at 1:1000, or constitutive NOS (cNOS, neuronal or brain NOS) at 1:175 in 3% milk. Membranes were then incubated for 1 h with the appropriate secondary (anti-rabbit horseradish peroxidase or anti-mouse horseradish peroxidase, 1:2000) in 3% milk, and then developed using ECL.
In Vitro Superoxide Measurements-Saturated potassium superoxide (KO 2 ) solution was made by mixing KO 2 in dimethyl sulfoxide, centrifuging at 1500 rpm for 5 min, and then decanting the supernatant (24) . This procedure yields about 3.6 mM solution (28) . The stock solution of KO 2 was then added to buffer containing 10 M HEt (for a final concentration of 150 M), and Et fluorescence was monitored every 20 s for 160 s, using a fluorometer. The superoxide level was determined from the slope of the increase in Et fluorescence over time, fit by linear regression. When indicated, BH 4 was added immediately prior to adding KO 2 , at final concentrations ranging from 20 nM to 200 M. Cu,Zn-SOD (9 units/ml) was used as a control.
The effects of BH 4 on KO 2 -generated superoxide levels were also measured by electron paramagnetic resonance (EPR) spectrometry using a spin trapping agent 5-diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide (DEPMPO) (19, 29) . DEPMPO was prepared as a 40 mM solution in 50 mM sodium phosphate buffer, pH 7.4, treated with an iron chelator, diethylenetriaminepentaacetic acid (N,N-bis[2-(bis[carboxymethyl]amino)ethyl]glycine) (DPTA) (1 mM). Catalase (300 units/ml) was also added to prevent other oxygen radicals from contaminating the EPR spectra. Spectra were recorded within 1 min after mixing, with a Varian E-12 EPR spectrometer equipped with a century series bridge (E-102) and a TM011 cavity mounted horizontally in the magnet. EPR spectra were recorded at X-band (9.45 GHz), using 30 mW of power, a time constant of 0.1 s, and modulation amplitude of 0.5 G. Spectra were acquired in 30 s. The mean and standard error of the signal amplitude was calculated as the signal height of the 5th line of the DEPMPO spectrum taken from 9 to 10 measurements from each of three separate experiments.
Statistical Analysis-Statistical analyses were performed using the GB-STAT statistical package (Dynamic Microsystems, Silver Spring, MD). Standard errors were calculated for each mean, and statistical differences between groups were determined by ANOVA followed by Newman-Keuls post-hoc test as indicated.
Materials-Dulbecco's modified Eagle's medium and calcium-and magnesium-free Hanks' balanced salt solution were purchased from Life Technologies, Inc. (Grand Island, NY); and fetal bovine serum from Intergen (Purchase, NY). Trypsin was purchased from Worthington Biochemical Corp. (Freehold, NJ); 15-mm diameter glass coverslips from Carolina Biological (Burlington, NC); 2,4-diamino-6-hydroxypyri-
arginine methyl ester (L-NAME), DPTA, and potassium superoxide from Sigma, DEMPPO from OXIS Health Products (Portland, OR). Antibodies against TH antiserum were obtained from Pel-Freez (Rogers, AR); antibodies against eNOS, iNOS, and cNOS from Biomol (Plymouth Meeting, PA); Vectastain ABC kit from Vector Laboratories (Burlingame, CA); mouse macrophage RAW 264.7 and bovine pulmonary artery endothelium cell lines were obtained from ATCC (Manassas, VA); and whole rat brain extract from Biomol (Plymouth Meeting, PA). HEt and 2,7-dichlorodihydrofluorescein were from Molecular Probes (Eugene, OR), sepiapterin from RBI (Natick, MA), and BH 4 from Schircks (Jona, Switzerland). SDS-polyacrylamide electrophoresis gel and polyvinylidene difluoride membranes were from Novex (Carlsbad, CA).
RESULTS

BH 4 Decreases Superoxide in Primary Mesencephalic
Neurons-We first examined the effects of BH 4 on superoxide levels in individual mesencephalic dopaminergic and nondopaminergic neurons using Et fluorescence. Dopaminergic (n ϭ 56) neurons had significantly lower baseline levels of superoxide than nondopaminergic neurons (n ϭ 924), consistent with the endogenous presence of BH 4 within dopaminergic neurons (Fig.  1) . Sepiapterin (20 M) is converted to BH 4 intracellularly (30), and increases BH 4 levels in total mesencephalic neurons com-parable to those in dopaminergic neurons (31) . Sepiapterin significantly decreased superoxide in nondopaminergic neurons to levels comparable to those in dopaminergic neurons, without further decreasing superoxide in dopaminergic neurons (n ϭ 246 and 14, respectively) ( Fig. 1) . To decrease BH 4 levels, we inhibited BH 4 synthesis using DAHP (1 mM) and NAS (0.1 mM). Each of these compounds decreases BH 4 to less than 5% of control levels in cell lines (30) . In mesencephalic neurons, DAHP and NAS in combination decrease BH 4 levels to about 16% of control (15) . BH 4 depletion increased superoxide in dopaminergic neurons without affecting superoxide in nondopaminergic neurons (n ϭ 20 and 316, respectively). Furthermore, BH 4 depletion increased superoxide levels in dopaminergic neurons beyond the levels of nondopaminergic neurons. The observation that DAHP and NAS failed to alter BH 4 levels in nondopaminergic neurons is consistent with the absence of endogenous BH 4 in these cells. Therefore, superoxide levels are inversely related to BH 4 levels in mesencephalic neurons.
BH 4 Decreases ROS Independent of Catecholamines and NOS-BH 4 is employed as a required cofactor by catecholamine synthesis enzymes and by nitric-oxide synthase, both of which are expressed in our cultures of mesencephalic neurons. Because products of both these enzyme systems can modulate superoxide production, altering BH 4 levels in mesencephalic cultures could indirectly modulate superoxide by affecting levels of catecholamines or NO. To understand BH 4 effects on superoxide levels in the absence of BH 4 -dependent enzymes, we examined superoxide levels in primary cultures of fibroblasts (PF) and cultures of a fibroblast line genetically engineered to express GTP cyclohydrolase 1 (PFG), the ratelimiting enzyme in BH 4 synthesis. Neither of these cell types synthesizes catecholamines. PFG produce BH 4 but not L-DOPA or dopamine (32) .
PFG produced BH 4 and PF did not (Table I) . PFG also had much lower levels of superoxide compared with PF (Fig. 2K) . Addition of sepiapterin (20 M) to PF markedly increased BH 4 levels (Table I ) and also decreased Et fluorescence dramatically compared with controls (Fig. 2K) . The decreased superoxide level in sepiapterin-treated PF was comparable to superoxide levels in PFG (Fig. 2K) . Inhibition of BH 4 synthesis in PFG by DAHP (1 mM) and NAS (1 mM) decreased BH 4 PFG to undetectable levels (Table I) , and increased superoxide levels. These data indicate that BH 4 is sufficient to decrease superoxide, independent of its role as a cofactor for dopamine synthesis.
To determine if BH 4 lowers ROS through its effect on NOS, we examined whether fibroblasts express NOS. NOS has been shown to produce superoxide instead of NO in the absence of BH 4 and NO can also scavenge superoxide (33) . Western blot analyses did not detect eNOS, iNOS, or cNOS expression in either PF or PFG (Fig. 3) . To provide further evidence for the absence of NOS effect on superoxide levels in our system, we examined the effect of L-NAME on superoxide levels. Treatment of fibroblasts with L-NAME (1 mM) for 2 h had no significant effect on basal superoxide levels or following treatment with sepiapterin (20 M) (Table II) . These data indicate that BH 4 decreases superoxide levels in fibroblasts independent of NOS.
To further investigate the effects of BH 4 on ROS, we employed DCF fluorescence. Oxidation of 2,7-dichlorodihydrofluorescein to DCF by various ROS and reactive nitrogen species has been noted (27) . Sepiapterin (20 M) decreased DCF fluorescence in PF (Fig. 2L) , and PFG had lower levels of DCF fluorescence than PF (Fig. 2L) . In addition, inhibition of BH 4 synthesis in PFG by DAHP (1 mM) and NAS (1 mM) increased DCF fluorescence. These DCF data were consistent with our Et fluorescence data. Taken together, our data using Et and DCF fluorescence suggest that BH 4 decreases both superoxide and downstream superoxide metabolites such as peroxides and other ROS.
BH 4 Decreases Mitochondrial ROS-In order to assess the effects of BH 4 on mitochondrial production of superoxide, rotenone and antimycin A were used to block electron transport distal to the primary sites of superoxide formation in complexes I and III, respectively (10, 34 -36) . Both rotenone (20 nM) and antimycin A (1 M) significantly increased superoxide levels in control fibroblasts. In both cases, this increase in superoxide was significantly attenuated in cells that either expressed BH 4 or were pretreated with sepiapterin (Fig. 4) . These data indicate that BH 4 either interferes with mitochondrial ROS generation, directly scavenges ROS formed within mitochondria, or both.
Mitochodrial depolarization-induced release of ethidium and subsequent fluorescence enhancement following binding to nucleic acids can complicate the interpretation of ethidium-based methods of superoxide measurement (37) . To test for this complication in our system, we used myxothiazole to depolarize mitochondria without increasing superoxide production. Treatment of fibroblasts with myxothiazole (2 M) plus oligomycin (2 g/ml) inhibited the slow Et fluorescence increase observed under baseline conditions (data not shown). In addition, subsequent treatment with carbonyl cyanide p-trifluoromethoxyphenylhydrazone (1 M) did not produce an increase in Et fluorescence, demonstrating the lack of artifactual increase in Et fluorescence under our experimental conditions. BH 4 Directly Scavenges ROS-To investigate whether BH 4 can scavenge superoxide directly, we used an in vitro model of KO 2 -generated superoxide (24, 38) . Consistent with previous FIG. 1. Superoxide levels of individual mesencephalic neurons. Superoxide levels were estimated in individual living mesencephalic neurons using HEt microfluorimetry as described previously (24) . Cells were then processed for TH-immunohistochemistry, and the original field of cells was relocated to identify dopaminergic neurons. Sepiapterin (20 M) (S) was given to provide BH 4 intracellularly while DAHP (1 mM) and NAS (0.1 mM) (NϩD) were used to block BH 4 synthesis. Superoxide levels were normalized to the mean superoxide in control nondopaminergic neurons. Data are expressed as mean Ϯ S.E. 4 . Therefore, to provide more direct evidence that BH 4 scavenges superoxide, we also used EPR with the spin trapping agent DEPMPO. DEPMPO is more sensitive and specific for superoxide detection than other spin traps, due to the formation of a more stable adduct (19, 29) . The mean signal height of the fifth line of the DEPMPO spectrum corresponding to superoxide was 275.9 Ϯ 7.5 (S.E., an arbitrary unit, n ϭ 27) in the KO 2 (50 M) group. This value was attenuated to 127.7 Ϯ 2.7 (n ϭ 30, p Ͻ 0.01 by Fisher's LSD protected t-test) when 200 M BH 4 was added to the mixture (Fig. 6) . There was no detectable superoxide signal when SOD (100 units/ml) was added as a positive 
FIG. 3. NOS expression in fibroblasts.
NOS expression was examined in PF and PFG by Western blot analysis using antibodies against cNOS, eNOS, and iNOS. Positive controls were obtained from extracts of mouse macrophage RAW 264.7 cells treated for 16 h with lipopolysaccharide (30 g/ml) prior to harvest for iNOS (iN), bovine pulmonary artery endothelial cells for eNOS (eN), and whole brain extract from rat (10 g) for cNOS (cN). St, standard; B, blank. The expected molecular weight of each NOS protein is indicated.
TABLE II Effect of NOS inhibitor on superoxide levels
Fibroblasts (PF) were treated with or without L-NAME (1 mM) for 2 h in the presence or absence of sepiapterin (20 M) (PF/S) and superoxide levels were measured by the Et fluorescence method. Et fluorescence values are normalized to the mean level in untreated PF. Data are expressed as mean Ϯ SE. control to scavenge superoxide (Fig. 6C) . Taken together, these data strongly suggest that BH 4 decreases ROS through a direct scavenging mechanism.
DISCUSSION
This study provides the first evidence for intrinsic differences in antioxidant capacity between dopaminergic and nondopaminergic neurons. Dopaminergic neurons have intrinsically lower levels of superoxide than nondopaminergic neurons, consistent with their increased resistance to oxidative stresses such as glutathione depletion (14, 15, 31) . In addition, our data indicate that physiologic levels of BH 4 within dopaminergic neurons are necessary and sufficient for maintaining lower ROS, since the inhibition of BH 4 synthesis selectively increased ROS within dopaminergic neurons and providing exogenous BH 4 selectively decreased ROS in nondopaminergic neurons. Our data further demonstrate that BH 4 decreases ROS generated from mitochondria and does so independent of any effect on dopamine synthesis or NOS. Finally, our in vitro experiments show that BH 4 scavenges superoxide directly.
The lower ROS level in dopaminergic neurons is surprising given the overwhelming evidence for oxidative stress in PD and the selective degeneration of dopaminergic neurons in PD. One possible explanation is that the balance of oxidative stress to antioxidant defense in cultured rodent fetal mesencephalic neurons may be different from adult human dopaminergic neurons in vivo. In addition, the intrinsic oxidative capacity of dopaminergic neurons in the normal state may be different from that in disease states. Dopaminergic neurons are also likely to face a higher baseline level of oxidative stress, due to ROS formed from the degradation of dopamine. Thus, monoamine oxidase metabolizes dopamine to H 2 O 2 , which may be detoxified primarily by the glutathione/glutathione peroxidase system. In addition, ROS may be generated by TH through partial uncoupling of the hydroxylation reaction (39) . Therefore, in order for normal dopaminergic neurons to survive, they may require an intrinsically increased antioxidant capacity.
Our results suggest that BH 4 provides an intrinsic antioxidant capacity unique to dopaminergic neurons. Thus, BH 4 protects against L-buthionine-[S,R]-sulfoximine (15) , H 2 O 2 , UV light (22) , and paraquat toxicity (40) . Compared with nondopaminergic neurons, dopaminergic neurons are also more resistant to NO toxicity, but equally vulnerable to peroxynitrite toxicity (41, 42) . This observation, together with the fact that superoxide reacts rapidly with NO to form toxic peroxynitrite anions, led Sawada et al. (41, 42) to hypothesize that normal dopaminergic neurons have low superoxide levels. The protective effect of decreased superoxide against NO toxicity has also been inferred from data showing that high levels of MnSOD are protective (43) . Our data provide direct evidence supporting the hypothesis that dopaminergic neurons have low superoxide levels and demonstrate that lower superoxide levels in dopaminergic neurons is due to BH 4 . BH 4 could lower superoxide levels by interfering with the production of superoxide or by scavenging it. In most cell types, mitochondria are the major site of superoxide generation (44, 45) , and their metabolic products such as H 2 O 2 , peroxynitrite anions, and hydroxyl radicals constitute the majority of intracellular ROS. BH 4 attenuated the superoxide levels generated by mitochondrial inhibitors such as rotenone and antimycin A (Fig. 4) . Once superoxide is formed its two most characterized fates are SOD-catalyzed dismutation to H 2 O 2 and reaction with NO to form toxic peroxynitrite anions. BH 4 functions as an essential cofactor for NOS (46) , and NOS can be uncoupled to produce superoxide when concentrations of either BH 4 or the substrate arginine are suboptimal (19, 33) . Conversely, NOS can also decrease superoxide levels, since NO formed by NOS reacts rapidly with superoxide to form peroxynitrite (47) . Therefore, BH 4 could lower superoxide levels both by decreasing production by NOS (48, 49) , and by increasing superoxide scavenging by NO. To examine whether there are direct effects of BH 4 on superoxide independent of NOS, we used fibroblasts that do not express NOS (Fig. 3) . These fibroblasts had lower superoxide levels than control fibroblasts when genetically modified to produce BH 4 or provided with the BH 4 precursor sepiapterin (Fig. 2K) . Thus, the superoxide lowering effect of BH 4 is not mediated through NO.
We provide the first direct evidence that BH 4 scavenges superoxide, by showing its effect on superoxide generated nonenzymatically by KO 2 (24) using both Et fluorescence and EPR measurements. Although BH 4 has previously been hypothesized to scavenge superoxide directly, these studies generated superoxide by xanthine/xanthine oxidase or a macrophage/ phorbol myristate acetate reaction system (16, 17, 19, 22, 40) , and hence BH 4 could have inhibited these superoxide generating enzymes. We saw a BH 4 -mediated decrease in superoxide levels at a range of concentrations (2-200 M) similar to the estimated concentrations of BH 4 in nigrostriatal dopaminergic neurons (50) . Furthermore, the observation that BH 4 significantly attenuates basal superoxide levels within dopaminergic neurons in culture demonstrates the physiological relevance of its effect.
A potential relationship between the role of BH 4 as an antioxidant and the pathogenesis of PD is a tantalizing idea. Dopaminergic neurons in the SN have lower levels of GTP cyclohydrolase 1 mRNA than dopaminergic neurons in the VTA (51) , and lower GTP cyclohydrolase 1 protein than norepinephrine neurons in the locus ceruleus or serotonergic neurons in the dorsal raphe nucleus (52) , and are therefore presumed to have comparatively low levels of BH 4 . Low levels of BH 4 could contribute to the greater susceptibility of dopaminergic neurons in the SN versus other catecholaminergic neurons in PD. In addition, the strongest known risk factor for PD is age, and BH 4 levels are known to decrease significantly with increasing age in mice (53) and humans (54) . In particular, Chen et al. (55) reported that the number of GTP cyclohydrolase 1-immunoreactive nigral neurons were decreased more than TH-immunoreactive neurons in aged monkeys.
In conclusion, BH 4 directly scavenges superoxide, and thereby provides dopaminergic neurons with an enhanced antioxidant capacity. We propose that this intrinsic resistance of dopaminergic neurons to oxidative stress is critical to their survival, and disturbances in this capacity through genetic mutations or exposure to exogenous toxins could underlie their demise in PD. Understanding these processes may lead to therapeutic interventions to protect both dopaminergic and nondopaminergic neurons from a variety of oxidative stressors.
